MetadataShow full item record
DescriptionResearchers at the University of Maryland School of Medicine (UMSOM) have begun participation in the Phase 3 clinical trial of an investigational COVID-19 vaccine co-developed by scientists at Moderna Inc. and the National Institute of Allergy and Infectious Diseases (NIAID), part of the National Institutes of Health (NIH). Video includes brief interview with UMB President, Bruce E. Jarrell, MD, FACS, who is a participant in the trial.
KeywordCoronavirus Disease 2019 (COVID-19)
National Institute of Allergy and Infectious Diseases (U.S.)
University of Maryland, Baltimore. School of Medicine
Clinical Trial, Phase III